Form 4: ClearPoint Neuro Director R. John Fletcher Acquires Shares as Part of Compensation Plan

Director R. John Fletcher acquired 486 shares of ClearPoint Neuro, Inc. common stock on April 1, 2025, as part of the company's Non-Employee Director Compensation Plan.

Summary

• On April 1, 2025, R. John Fletcher, a director of ClearPoint Neuro, Inc., acquired 486 shares of common stock.
• The acquisition was made under the company's Fifth Amended and Restated 2013 Incentive Compensation Plan, as payment for director fees.
• The shares were issued at a price of $11.89 per share, which was the closing price of ClearPoint Neuro's common stock on March 31, 2025.
• Following the transaction, Fletcher directly owns 94,398 shares of ClearPoint Neuro, Inc.
• Fletcher has also granted a Power of Attorney to Joseph M. Burnett, Ellisa Cholapranee, Danilo D'Alessandro, Jeremy Stigall, and Mazin Sabra to handle Section 16 reporting requirements.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to positively as it aligns director interests with shareholders.

Positives

• The acquisition of shares by a director demonstrates alignment with the company's interests.
• The use of equity as part of director compensation can help conserve cash.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

This type of transaction is common for directors of publicly traded companies, often used as part of their compensation packages to align their interests with those of shareholders.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash and equity.
• Companies like Medtronic and Stryker also use equity-based compensation for their directors.
• The amount of equity granted varies based on company size, performance, and industry benchmarks.

Related Party Transactions

• The share issuance to R. John Fletcher as part of the Non-Employee Director Compensation Plan constitutes a related party transaction.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with theirs.
• The transaction has a positive impact on the director as it provides compensation for their services.

Key Dates

Keywords

ClearPoint Neuro, Director, Share Acquisition, Form 4, R. John Fletcher, Compensation Plan, Power of Attorney, Section 16